DuPont and MRM Health to develop microbiome products
Collaborations aim to discover and develop therapies for metabolic diseases. MRM Health also announced that it raised more than €14m to advance its clinical and preclinical development programs in the field of microbiome-based therapeutics with partner participation.
2020-02-20 DuPont Nutrition & Biosciences

iConnectHub
Login/Register
Supplier Login











Home












